Derivative Claims: When Can You Sue on Behalf of the Company?

Derivative Claims: When Can You Sue on Behalf of the Company?

TLDR

A derivative claim allows shareholders to act on behalf of the company when directors breach their duty or misuse assets. Court permission is required, and any recovery benefits the company, not individuals. It is a vital mechanism for enforcing accountability, protecting corporate interests, and maintaining proper governance when management fails.

A derivative claim allows a shareholder or, in some jurisdictions, an officer or former officer, to sue on behalf of the company when the management fails or refuses to do so, typically because the managers themselves are the wrongdoers. The lawsuit addresses a wrong done to the corporation itself, with any recovery going to the company, not the individual who brings the claim.

This article explains when a shareholder can bring a derivative claim, the legal and procedural requirements, and the types of corporate misconduct that can justify such action. It also outlines how the courts assess whether continuing the claim serves the best interests of the company and what remedies are available if it succeeds.

The Legal Purpose of Derivative Claims

Derivative proceedings exist to protect the company where those who should act will not. They overcome the classic rule in Foss v. Harbottle by allowing minority shareholders to enforce their rights when control rests with the alleged wrongdoers. The purpose is to align outcomes with the best interests of the company. 

Key policy goals include deterrence of director misconduct, safeguarding corporate property, and maintaining investor confidence. In practice, the court tests whether continuing the litigation serves the company’s interests rather than the private interests of one shareholder.

Who Can Bring a Derivative Claim

Under the Companies Act 2006, only a member of the company can bring a statutory derivative claim. The claim is in respect of a cause of action vested in the company and seeks relief for the company. The claimant must act in good faith and be able to fairly represent the company’s interests. 

UK statute does not impose a formal contemporaneous ownership rule, although timing and the claimant’s motives are relevant to the court’s permission analysis. In some other common law jurisdictions, additional standing rules apply and may require the claimant to have held shares at the time of the alleged wrongdoing.

Procedural requirements before suing

In England and Wales, there is no statutory requirement to make a pre-action “demand” on the board. The focus is on the court’s permission process. The Civil Procedure Rules require an application for permission supported by evidence, and the Companies Act 2006 sets a structured test:

  • Prima facie stage: the court reviews the papers. If there is no arguable case on liability or no real prospect that the claim benefits the company, permission is refused.
  • Inter partes stage: if the case passes the paper filter, the court considers discretionary factors. These include whether a director acting in accordance with the duty to promote the success of the company would continue the claim, the availability of alternative remedies, any ratification or likely ratification, the claimant’s good faith, views of independent shareholders, proportionality, and cost benefit.

Good practice remains to follow the Pre-Action Protocol where appropriate and to document any engagement with the board, especially if conflicts or control issues suggest that internal action is unrealistic.

Common Grounds for Derivative Claims

A derivative claim must target a wrong to the company. Typical grounds include:

  • Breach of fiduciary duty, such as failure to avoid conflicts of interest, secret profits, or misuse of confidential information.
  • Breach of the duty to promote the success of the company under section 172, for example, approving a value-destroying related party transaction.
  • Self-dealing and diversion of corporate opportunities to connected entities.
  • Misappropriation of company funds, unlawful distributions, or corporate waste.
  • Fraud, dishonest assistance, or knowing receipt involving directors or shadow directors.

These are company-level harms. If the issue is prejudiced to an individual member, a different route, such as an unfair prejudice petition under section 994, may be more suitable.

Outcomes and Remedies

If permission is granted and the claim succeeds, the remedy belongs to the company. The court may award damages to the company, unwind an unlawful transaction, grant an injunction, or make a declaratory order. In suitable cases, the court can require directors to account for profits earned through self-dealing or conflicts of interest. The court may also set aside transactions entered into in breach of fiduciary duty or without proper authority.

Costs follow the event, but the court has flexibility. A claimant who has acted responsibly may obtain a costs indemnity from the company, usually through a case management order, where the claim appears to be in the company’s best interests. The court can also limit or revoke any indemnity if later evidence shows the claim lacks merit.

Strategic Considerations and Risks

Derivative proceedings are powerful but resource-intensive. Before applying for permission, weigh the following:

  • Best interests of the company: The section 263 test asks whether a director acting under section 172 would continue the claim. A weak cost-benefit case will struggle for permission.
  • Alternative remedies: If the real complaint is prejudice to a member, an unfair prejudice petition under section 994 may offer a faster and more tailored outcome, such as a share buyout at fair value.
  • Ratification risk: If truly independent shareholders have authorised or would authorise the conduct, permission is likely to be refused.
  • Evidence and valuation: Strong documentary evidence supports the prima facie stage. Financial analysis, forensic accounting, and clear causation of company loss strengthen prospects.
  • Funding and adverse costs: Consider applications for a company indemnity for costs, after-the-event insurance, or third-party funding. If permission is refused, adverse costs may be ordered.
  • Limitation periods: Most claims for breach of duty are subject to a six-year period under the Limitation Act 1980. Fraud or deliberate concealment can extend the time.

Get to know: Unfair Prejudice Claims (s.994): Strategy and Outcomes

How Our Civil Litigation Team Can Help

At Civil Litigation Lawyers, we assess standing, jurisdiction, and the statutory gateway under sections 260 to 263. We also test the merits against fiduciary duty standards, identify conflicts, and quantify loss at the company level.

Our team prepares a focused permission application, supported by witness statements, documentary exhibits, and expert input, when valuation or forensic accounting is required. We map alternative remedies to ensure the chosen route aligns with the company’s best interests and the court’s expectations.

Contact us today for clear, strategic guidance on pursuing justice on behalf of your company.

You Ask, We Answer

FAQs

A derivative claim is brought on behalf of the company to remedy a wrong done to it, while a direct claim is brought by a shareholder to address personal loss. The key distinction lies in who suffered the harm and who ultimately benefits from the remedy.

Yes. A minority shareholder can apply for court permission if the board or controlling shareholders are involved in the wrongdoing. The court assesses whether the claim serves the company’s best interests and whether independent shareholders would support continuing the action.

If the board resolves to pursue the same claim independently and demonstrates genuine intention, the court may refuse permission for the shareholder’s derivative action. The rationale is to avoid duplicating proceedings or undermining proper corporate management structures.

Yes. The court encourages settlement if the resolution benefits the company and avoids unnecessary costs. Any proposed settlement must be disclosed to the court, and approval is generally required to ensure fairness and consistency with corporate interests.

No. Both private and public companies fall under the Companies Act 2006 framework. However, practical use is more common in private companies, where minority shareholders have limited control and greater exposure to management misconduct or related-party abuse.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *